Observational studyBMC geriatrics2026
Frailty in older patients with cancer in Vietnam.
Observational study in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
aimsThis study aimed to quantify the prevalence of frailty, and investigate the impact of frailty on adverse outcomes, in older patients with cancer in Vietnam.
methodsA prospective, observational study was conducted in adults aged 65 or above with cancer who attended the outpatient clinics of two urban hospitals in Vietnam from September 2023 to May 2024. Frailty was defined by the Carolina Frailty Index (CFI) and participants with a CFI >0.35 were identified as frail. All participants were followed up for 3 months after discharge, recording falls, all-cause hospitalization, and all-cause mortality.
resultsThere were 379 participants (mean age 72.3 years, 48.5% female). The prevalence of frailty was 26.6% (95%CI 22.2% - 31.0%), highest in participants with stomach cancer (35.7%) and lung cancer (33.9%). Participants with advanced stages of cancer had a significantly higher prevalence of frailty: 39.3% in stage 4, 21.7% in stage 3, compared to 18.1% in stage 2 and 13.0% in stage 1. During the follow up, 19.0% of the participants had a fall (44.4% in the frail vs. 9.7% in the non-frail, p<0.001), 33.4% were admitted to hospitals (42.2% in the frail vs. 30.1% in the non-frail, p=0.026). The mortality rate was 1.9% (5.1% in the frail vs. 0.7% in the non-frail, p=0.017). Odds ratios were 7.48 (95%CI 4.24 - 13.40, p<0.001) for falls, 1.71 (95%CI 1.06 - 2.75, p=0.027) for all-cause hospitalization, and 7.10 (95%CI 1.36 - 37.22, p=0.020) for all-cause mortality.
conclusionFrailty was common among the participants, with the highest prevalence among those with stomach and lung cancer. Frailty significantly increased the odds of falls, hospitalization, and mortality in three months post-discharge. Further research is needed to gain a better understanding of the impact of frailty on adverse outcomes, and the quality of life for older adults with cancer in Vietnam.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.